Elutia Inc. (NASDAQ: ELUT) had its price target raised by analysts at Lake Street Capital from $5.00 to $10.00. They now have a "buy" rating on the stock.
Elutia Inc. (NASDAQ: ELUT) had its price target raised by analysts at Cantor Fitzgerald from $5.00 to $11.00. They now have an "overweight" rating on the stock.
Elutia Announces $13.26 Million Registered Direct Offering
Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators
Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024